Diabetes is a leading cause of end-stage renal disease. Therefore, prevention of renal dysfunction is an important treatment goal in the management of diabetes. The data of landmark cardiovascular outcome trials of sodium-glucose cotransporter-2 (SGLT2) inhibitor showed profound reno-protective effects. The Korean Diabetes Association and the Korean Society of Nephrology reviewed clinical trials and performed meta-analysis to assess the effects of SGLT2 inhibitors on the preservation of estimated glomerular filtration rate (eGFR). We limited the data of SGLT2 inhibitors which can be prescribed in Korea. Both eGFR value and its change from the baseline were significantly more preserved in the SGLT2 inhibitor treatment group compared to the control group after 156 weeks. However, some known adverse events were increased in SGLT2 inhibitor treatment, such as genital infection, diabetic ketoacidosis, and volume depletion. We recommend the long-term use SGLT2 inhibitor in patients with type 2 diabetes mellitus (T2DM) for attenuation of renal function decline. However, we cannot generalize our recommendation due to lack of long-term clinical trials testing reno-protective effects of every SGLT2 inhibitor in a broad range of patients with T2DM. This recommendation can be revised and updated after publication of several large-scale renal outcome trials.

Citations

Citations to this article as recorded by  

• Real-World Treatment Patterns according to Clinical Practice Guidelines in Patients with Type 2 Diabetes Mellitus and Established Cardiovascular Disease in Korea: Multicenter, Retrospective, Observational Study
  Ye Seul Yang, Nam Hoon Kim, Jong Ha Baek, Seung-Hyun Ko, Jang Won Son, Seung-Hwan Lee, Sang Youl Rhee, Soo-Kyung Kim, Tae Seo Sohn, Ji Eun Jun, In-Kyung Jeong, Chong Hwa Kim, Keeho Song, Eun-Jung Rhee, Junghyun Noh, Kyu Yeon Hur
  Diabetes & Metabolism Journal.2024; 48(2): 279.     CrossRef
• Renoprotective Mechanism of Sodium-Glucose Cotransporter 2 Inhibitors: Focusing on Renal Hemodynamics
  Nam Hoon Kim, Nan Hee Kim
  Diabetes & Metabolism Journal.2022; 46(4): 543.     CrossRef
• Real-World Prescription Patterns and Barriers Related to the Use of Sodium-Glucose Cotransporter 2 Inhibitors among Korean Patients with Type 2 Diabetes Mellitus and Cardiovascular Disease
  Jong Ha Baek, Ye Seul Yang, Seung-Hyun Ko, Kyung Do Han, Jae Hyeon Kim, Min Kyong Moon, Jong Suk Park, Byung-Wan Lee, Tae Jung Oh, Suk Chon, Jong Han Choi, Kyu Yeon Hur
  Diabetes & Metabolism Journal.2022; 46(5): 701.     CrossRef

Cyclic adenosine monophosphate (cAMP) signaling is critical for regulating metabolic homeostasis in mammals. In particular, transcriptional regulation by cAMP response element-binding protein (CREB) and its coactivator, CREB-regulated transcription coactivator (CRTC), is essential for controlling the expression of critical enzymes in the metabolic process, leading to more chronic changes in metabolic flux. Among the CRTC isoforms, CRTC2 is predominantly expressed in peripheral tissues and has been shown to be associated with various metabolic pathways in tissue-specific manners. While initial reports showed the physiological role of CRTC2 in regulating gluconeogenesis in the liver, recent studies have further delineated the role of this transcriptional coactivator in the regulation of glucose and lipid metabolism in various tissues, including the liver, pancreatic islets, endocrine tissues of the small intestines, and adipose tissues. In this review, we discuss recent studies that have utilized knockout mouse models to delineate the role of CRTC2 in the regulation of metabolic homeostasis.

Citations

Citations to this article as recorded by  

• Integration of genomic and transcriptomic data of inbred mouse models for polygenic obesity and leanness revealed “obese” and “lean” candidate alleles in polyadenylation signals
  Martin Šimon, Špela Mikec, Nicholas M. Morton, Santosh S. Atanur, Simon Horvat, Tanja Kunej
  Gene Reports.2024; 35: 101903.     CrossRef
• Mylabris phalerata induces the apoptosis and cell cycle delay in HCC, and potentiates the effect of sorafenib based on the molecular and network pharmacology approach
  Young Woo Kim, Seon Been Bak, Su Youn Baek, Il Kon Kim, Won-Yung Lee, Un-Jung Yun, Kwang-Il Park
  Molecular & Cellular Toxicology.2023; 19(4): 731.     CrossRef
• Emerging Role of SMILE in Liver Metabolism
  Nanthini Sadasivam, Kamalakannan Radhakrishnan, Hueng-Sik Choi, Don-Kyu Kim
  International Journal of Molecular Sciences.2023; 24(3): 2907.     CrossRef
• PIMT regulates hepatic gluconeogenesis in mice
  Bandish Kapadia, Soma Behera, Sireesh T. Kumar, Tapan Shah, Rebecca Kristina Edwin, Phanithi Prakash Babu, Partha Chakrabarti, Kishore V.L. Parsa, Parimal Misra
  iScience.2023; 26(3): 106120.     CrossRef
• Biological functions of CRTC2 and its role in metabolism-related diseases
  Hong-Yu Zheng, Yan-Xia Wang, Kun Zhou, Hai-Lin Xie, Zhong Ren, Hui-Ting Liu, Yang-Shao Ou, Zhi-Xiang Zhou, Zhi-Sheng Jiang
  Journal of Cell Communication and Signaling.2023; 17(3): 495.     CrossRef
• An insulin-regulated arrestin domain protein controls hepatic glucagon action
  Sezin Dagdeviren, Megan F. Hoang, Mohsen Sarikhani, Vanessa Meier, Jake C. Benoit, Marinna C. Okawa, Veronika Y. Melnik, Elisabeth M. Ricci-Blair, Natalie Foot, Randall H. Friedline, Xiaodi Hu, Lauren A. Tauer, Arvind Srinivasan, Maxim B. Prigozhin, Sudha
  Journal of Biological Chemistry.2023; 299(8): 105045.     CrossRef
• The Pleiotropic Face of CREB Family Transcription Factors
  Md. Arifur Rahman Chowdhury, Jungeun An, Sangyun Jeong
  Molecules and Cells.2023; 46(7): 399.     CrossRef
• It is a branched road to adipose tissue aging
  N. Touitou, B. Lerrer, H. Y. Cohen
  Nature Aging.2023; 3(8): 911.     CrossRef
• Impaired BCAA catabolism in adipose tissues promotes age-associated metabolic derangement
  Hye-Sook Han, Eunyong Ahn, Eun Seo Park, Tom Huh, Seri Choi, Yongmin Kwon, Byeong Hun Choi, Jueun Lee, Yoon Ha Choi, Yujin L. Jeong, Gwang Bin Lee, Minji Kim, Je Kyung Seong, Hyun Mu Shin, Hang-Rae Kim, Myeong Hee Moon, Jong Kyoung Kim, Geum-Sook Hwang, S
  Nature Aging.2023; 3(8): 982.     CrossRef
• Exploring the diagnostic value, prognostic value, and biological functions of NPC gene family members in hepatocellular carcinoma based on a multi-omics analysis
  Keheng Chen, Xin Zhang, Huixin Peng, Fengdie Huang, Guangyu Sun, Qijiang Xu, Lusheng Liao, Zhiyong Xing, Yanping Zhong, Zhichao Fang, Meihua Liao, Shihua Luo, Wencheng Chen, Mingyou Dong
  Functional & Integrative Genomics.2023;[Epub]     CrossRef
• MicroRNA regulation of AMPK in nonalcoholic fatty liver disease
  Hao Sun, Jongsook Kim Kemper
  Experimental & Molecular Medicine.2023; 55(9): 1974.     CrossRef
• Serine active site containing protein 1 depletion alters lipid metabolism and protects against high fat diet-induced obesity in mice
  Miaomiao Du, Xueyun Li, Fangyi Xiao, Yinxu Fu, Yu Shi, Sihan Guo, Lifang Chen, Lu Shen, Lan Wang, Huang Cheng, Hao Li, Anran Xie, Yaping Zhou, Kaiqiang Yang, Hezhi Fang, Jianxin Lyu, Qiongya Zhao
  Metabolism.2022; 134: 155244.     CrossRef
• cAMP Signaling in Cancer: A PKA-CREB and EPAC-Centric Approach
  Muhammad Bilal Ahmed, Abdullah A. A. Alghamdi, Salman Ul Islam, Joon-Seok Lee, Young-Sup Lee
  Cells.2022; 11(13): 2020.     CrossRef
• Hepatic Sam68 Regulates Systemic Glucose Homeostasis and Insulin Sensitivity
  Aijun Qiao, Wenxia Ma, Ying Jiang, Chaoshan Han, Baolong Yan, Junlan Zhou, Gangjian Qin
  International Journal of Molecular Sciences.2022; 23(19): 11469.     CrossRef
• The Role of Small Heterodimer Partner-Interacting Leucine Zipper (SMILE) as a Transcriptional Corepressor in Hepatic Glucose and Lipid Metabolism
  Woo-Ram Park, Byungyoon Choi, Nanthini Sadasivam, Don-Kyu Kim
  Trends in Agriculture & Life Sciences.2022; 60: 7.     CrossRef
• AMPK Localization: A Key to Differential Energy Regulation
  Qonita Afinanisa, Min Kyung Cho, Hyun-A Seong
  International Journal of Molecular Sciences.2021; 22(20): 10921.     CrossRef

Premature obesity-related mortality is caused by cardiovascular and pulmonary diseases, type 2 diabetes mellitus, physical disabilities, osteoarthritis, and certain types of cancer. Obesity is caused by a positive energy balance due to hyper-caloric nutrition, low physical activity, and energy expenditure. Overeating is partially driven by impaired homeostatic feedback of the peripheral energy status in obesity. However, food with its different qualities is a key driver for the reward driven hedonic feeding with tremendous consequences on calorie consumption. In addition to visual and olfactory cues, taste buds of the oral cavity process the earliest signals which affect the regulation of food intake, appetite and satiety. Therefore, taste buds may play a crucial role how food related signals are transmitted to the brain, particularly in priming the body for digestion during the cephalic phase. Indeed, obesity development is associated with a significant reduction in taste buds. Impaired taste bud sensitivity may play a causal role in the pathophysiology of obesity in children and adolescents. In addition, genetic variation in taste receptors has been linked to body weight regulation. This review discusses the importance of taste buds as contributing factors in the development of obesity and how obesity may affect the sense of taste, alterations in food preferences and eating behavior.

Citations

Citations to this article as recorded by  

• Chronic social defeat stress broadly inhibits gene expression in the peripheral taste system and alters taste responses in mice
  Katelyn Tu, Mary Zhou, Jidong J. Tan, Loza Markos, Cameron Cloud, Minliang Zhou, Naoki Hayashi, Nancy E. Rawson, Robert F. Margolskee, Hong Wang
  Physiology & Behavior.2024; 275: 114446.     CrossRef
• Commentary: Is obesity associated with taste alterations? a systematic review
  Marco Alessandrini, Alessandra Vezzoli, Simona Mrakic-Sposta, Sandro Malacrida, Alessandro Micarelli
  Frontiers in Endocrinology.2024;[Epub]     CrossRef
• The Obese Taste Bud study: Objectives and study design
  Alexander Kersten, Andrea Lorenz, Cita Nottmeier, Michael Schmidt, Anuschka Roesner, Florian Christoph Richter, Kristin Röhrborn, A. Veronica Witte, Sebastian Hahnel, Till Koehne, Matthias Blüher, Michael Stumvoll, Kerstin Rohde‐Zimmermann, Imke Schamarek
  Diabetes, Obesity and Metabolism.2024;[Epub]     CrossRef
• Testing reward processing models of obesity using in-the-moment assessments of subjective enjoyment of food and non-food activities
  Christina Chwyl, Erica M. LaFata, Sophie R. Abber, Adrienne S. Juarascio, Evan M. Forman
  Eating Behaviors.2023; 48: 101698.     CrossRef
• Taste Function in Adult Humans from Lean Condition to Stage II Obesity: Interactions with Biochemical Regulators, Dietary Habits, and Clinical Aspects
  Alessandro Micarelli, Alessandra Vezzoli, Sandro Malacrida, Beatrice Micarelli, Ilaria Misici, Valentina Carbini, Ilaria Iennaco, Sara Caputo, Simona Mrakic-Sposta, Marco Alessandrini
  Nutrients.2023; 15(5): 1114.     CrossRef
• Exposure to Obesogenic Environments during Perinatal Development Modulates Offspring Energy Balance Pathways in Adipose Tissue and Liver of Rodent Models
  Diana Sousa, Mariana Rocha, Andreia Amaro, Marcos Divino Ferreira-Junior, Keilah Valéria Naves Cavalcante, Tamaeh Monteiro-Alfredo, Cátia Barra, Daniela Rosendo-Silva, Lucas Paulo Jacinto Saavedra, José Magalhães, Armando Caseiro, Paulo Cezar de Freitas M
  Nutrients.2023; 15(5): 1281.     CrossRef
• Exercise modifies fatty acid perception and metabolism
  Deepankumar Shanmugamprema, Karthi Muthuswamy, Vinithra Ponnusamy, Gowtham Subramanian, Keerthana Vasanthakumar, Vasanth Krishnan, Selvakumar Subramaniam
  Acta Physiologica.2023;[Epub]     CrossRef
• The role of the oral microbiome in obesity and metabolic disease: potential systemic implications and effects on taste perception
  Imke Schamarek, Lars Anders, Rima M. Chakaroun, Peter Kovacs, Kerstin Rohde-Zimmermann
  Nutrition Journal.2023;[Epub]     CrossRef
• Smell, taste and food habits changes along body mass index increase: an observational study
  Alessandro Micarelli, Sandro Malacrida, Alessandra Vezzoli, Beatrice Micarelli, Ilaria Misici, Valentina Carbini, Sara Caputo, Simona Mrakic-Sposta, Marco Alessandrini
  European Archives of Oto-Rhino-Laryngology.2023; 280(12): 5595.     CrossRef
• Sweet-inhibiting effects of gurmarin on intake during repeated acute and long-term sugar exposure: A behavioural analysis using an animal model
  Raquel Rayo-Morales, Antonio Segura-Carretero, Nicolas Poirier, Loïc Briand, David Garcia-Burgos
  Journal of Functional Foods.2023; 108: 105743.     CrossRef
• Suppression of sweet taste-related responses by plant-derived bioactive compounds and eating. Part I: A systematic review in humans
  Raquel Rayo-Morales, Antonio Segura-Carretero, Isabel Borras-Linares, David Garcia-Burgos
  Heliyon.2023; 9(10): e19733.     CrossRef
• The oral microbial odyssey influencing chronic metabolic disease
  Upasana Gupta, Priyankar Dey
  Archives of Physiology and Biochemistry.2023; : 1.     CrossRef
• Taste of Fat and Obesity: Different Hypotheses and Our Point of View
  Laurent Brondel, Didier Quilliot, Thomas Mouillot, Naim Akhtar Khan, Philip Bastable, Vincent Boggio, Corinne Leloup, Luc Pénicaud
  Nutrients.2022; 14(3): 555.     CrossRef
• Effect of Obesity Surgery on Taste
  Alhanouf S. Al-Alsheikh, Shahd Alabdulkader, Brett Johnson, Anthony P. Goldstone, Alexander Dimitri Miras
  Nutrients.2022; 14(4): 866.     CrossRef
• Oral motor function in obesity
  Mariana Cristina Zanin Castro, Carla Manfredi dos Santos, Raquel Eduardo Lucas, Claudia Maria de Felício, Roberto Oliveira Dantas
  Journal of Oral Rehabilitation.2022; 49(5): 529.     CrossRef
• The Effect of Artificial Sweeteners Use on Sweet Taste Perception and Weight Loss Efficacy: A Review
  Klara Wilk, Wiktoria Korytek, Marta Pelczyńska, Małgorzata Moszak, Paweł Bogdański
  Nutrients.2022; 14(6): 1261.     CrossRef
• Effects of visual and aromatic stimulations on the perception of five fundamental tastes
  Mayu Itoh, Aya Kitagawa, Harumi Ouchi, Mana Yamaguchi, Ran Watanabe, Hideyuki Sone, Shin Kamiyama
  Bioscience, Biotechnology, and Biochemistry.2022; 86(5): 655.     CrossRef
• Taste and smell function in long-term survivors after childhood medulloblastoma/CNS-PNET
  Kristine Eidal Tanem, Einar Stensvold, Petter Wilberg, Anne B. Skaare, Preet Bano Singh, Petter Brandal, Bente Brokstad Herlofson
  Supportive Care in Cancer.2022; 30(7): 6155.     CrossRef
• Changes in Food Choice, Taste, Desire, and Enjoyment 1 Year after Sleeve Gastrectomy: A Prospective Study
  Luigi Schiavo, Silvana Mirella Aliberti, Pietro Calabrese, Anna Maria Senatore, Lucia Severino, Gerardo Sarno, Antonio Iannelli, Vincenzo Pilone
  Nutrients.2022; 14(10): 2060.     CrossRef
• Characterizing Adolescents' Dietary Intake by Taste: Results From the UK National Diet and Nutrition Survey
  Areej Bawajeeh, Michael A. Zulyniak, Charlotte E. L. Evans, Janet E. Cade
  Frontiers in Nutrition.2022;[Epub]     CrossRef
• Sleeve Gastrectomy-Induced Body Mass Index Reduction Increases the Intensity of Taste Perception’s and Reduces Bitter-Induced Pleasantness in Severe Obesity
  Sara Rurgo, Elena Cantone, Marcella Pesce, Eleonora Efficie, Mario Musella, Barbara Polese, Barbara De Conno, Marta Pagliaro, Luisa Seguella, Bruna Guida, Giuseppe Esposito, Giovanni Sarnelli
  Journal of Clinical Medicine.2022; 11(14): 3957.     CrossRef
• Genetic variation in sweet taste receptors and a mechanistic perspective on sweet and fat taste sensation in the context of obesity
  Vinithra Ponnusamy, Gowtham Subramanian, Karthi Muthuswamy, Deepankumar Shanmugamprema, Vasanth Krishnan, Thirunavukkarasu Velusamy, Selvakumar Subramaniam
  Obesity Reviews.2022;[Epub]     CrossRef
• Applying a systems perspective to understand the mechanisms of the European School Fruit and Vegetable Scheme
  Mahshid Zolfaghari, Biljana Meshkovska, Anna Banik, Carlijn B M Kamphuis, Birgit Kopainsky, Aleksandra Luszczynska, Celine Murrin, Nanna Lien
  European Journal of Public Health.2022; 32(Supplement): iv107.     CrossRef
• Self-Reported Sensory Decline in Older Adults Is Longitudinally Associated With Both Modality-General and Modality-Specific Factors
  Alan O’ Dowd, Rebecca J Hirst, Annalisa Setti, Rose Anne Kenny, Fiona N Newell, Nancy W Glynn
  Innovation in Aging.2022;[Epub]     CrossRef
• The sweet taste receptor, glucose transporters, and the ATP-sensitive K+ (KATP) channel: sugar sensing for the regulation of energy homeostasis
  Ryusuke Yoshida, Keiko Yasumatsu, Yuzo Ninomiya
  Current Opinion in Physiology.2021; 20: 57.     CrossRef
• Gustatory Function Can Improve after Multimodal Lifestyle Intervention: A Longitudinal Observational Study in Pediatric Patients with Obesity
  Laura Kalveram, Jacob Gohlisch, Jana Brauchmann, Johanna Overberg, Peter Kühnen, Susanna Wiegand
  Childhood Obesity.2021; 17(2): 136.     CrossRef
• Single nucleotide polymorphism in CD36: Correlation to peptide YY levels in obese and non-obese adults
  Muthuswamy Karthi, Shanmugamprema Deepankumar, Ponnusamy Vinithra, Subramanian Gowtham, Krishnan Vasanth, Palanivelu Praveen Raj, Rajasekaran Senthilkumar, Subramaniam Selvakumar
  Clinical Nutrition.2021; 40(5): 2707.     CrossRef
• Lezzet Algısının Oluşmasında Çevresel ve Genetik Faktörlerin Etkileri
  Mücahit MUSLU, Gülden Fatma GÖKÇAY
  Batı Karadeniz Tıp Dergisi.2021; 5(1): 7.     CrossRef
• Food Preferences and Obesity
  Sara Spinelli, Erminio Monteleone
  Endocrinology and Metabolism.2021; 36(2): 209.     CrossRef
• Western Diet Induced Remodelling of the Tongue Proteome
  Mriga Dutt, Yaan-Kit Ng, Jeffrey Molendijk, Hamzeh Karimkhanloo, Luoping Liao, Ronnie Blazev, Magdalene K. Montgomery, Matthew J. Watt, Benjamin L. Parker
  Proteomes.2021; 9(2): 22.     CrossRef
• Obesity-induced taste dysfunction, and its implications for dietary intake
  Fiona Harnischfeger, Robin Dando
  International Journal of Obesity.2021; 45(8): 1644.     CrossRef
• Recent Advances in Understanding Peripheral Taste Decoding I: 2010 to 2020
  Jea Hwa Jang, Obin Kwon, Seok Jun Moon, Yong Taek Jeong
  Endocrinology and Metabolism.2021; 36(3): 469.     CrossRef
• Smash of diabetes mellitus on smile
  Farhana Akter, Mainul Haque
  Advances in Human Biology.2021; 11(3): 273.     CrossRef
• Perception des acides gras et potentiels évoqués gustatifs : application dans l’obésité
  Thomas Mouillot, Laurent Brondel, Agnès Jacquin-Piques
  Cahiers de Nutrition et de Diététique.2021; 56(5): 280.     CrossRef
• Trastornos del gusto como indicador de enfermedad sistémica
  Karla Ivohnne Pedraza Maquera, Caroll Johana Uberlinda Lévano Villanueva
  Revista Odontológica Basadrina.2021; 5(2): 52.     CrossRef

Citations

Citations to this article as recorded by  

• Mechanisms and Perspectives of Sodium-Glucose Co-transporter 2 Inhibitors in Heart Failure
  Qingchun Zeng, Qing Zhou, Weitao Liu, Yutong Wang, Xingbo Xu, Dingli Xu
  Frontiers in Cardiovascular Medicine.2021;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Glycaemic outcomes in hospital with IDegAsp versus BIAsp30 premixed insulins
  Joshua R. Walt, Julie Loughran, Spiros Fourlanos, Rahul D. Barmanray, Jasmine Zhu, Suresh Varadarajan, Mervyn Kyi
  Internal Medicine Journal.2024;[Epub]     CrossRef
• Low fasting glucose‐to‐estimated average glucose ratio was associated with superior response to insulin degludec/aspart compared with basal insulin in patients with type 2 diabetes
  Han Na Jang, Ye Seul Yang, Tae Jung Oh, Bo Kyung Koo, Seong Ok Lee, Kyong Soo Park, Hak Chul Jang, Hye Seung Jung
  Journal of Diabetes Investigation.2022; 13(1): 85.     CrossRef
• Comparing time to intensification between insulin degludec/insulin aspart and insulin glargine: A single-center experience from India
  Rajiv Kovil
  Journal of Diabetology.2022; 13(2): 171.     CrossRef
• Use of Insulin Degludec/Insulin Aspart in the Management of Diabetes Mellitus: Expert Panel Recommendations on Appropriate Practice Patterns
  Tevfik Demir, Serap Turan, Kursad Unluhizarci, Oya Topaloglu, Tufan Tukek, Dilek Gogas Yavuz
  Frontiers in Endocrinology.2021;[Epub]     CrossRef
• Pharmacoeconomic comparison of the second generation insulin analogs and insulins on their base
  I. N. Dyakov, S. K. Zyryanov
  Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice.2021; 20(1): 4.     CrossRef
• Efficacy and Safety of Insulin Degludec/Insulin Aspart Compared with a Conventional Premixed Insulin or Basal Insulin: A Meta-Analysis
  Shinje Moon, Hye-Soo Chung, Yoon-Jung Kim, Jae-Myung Yu, Woo-Ju Jeong, Jiwon Park, Chang-Myung Oh
  Metabolites.2021; 11(9): 639.     CrossRef
• Insulin therapy in diabetic kidney disease
  Yan Liu, Chanyue Zhao, Xiaofen Xiong, Ming Yang, Lin Sun
  Diabetic Nephropathy.2021; 1(2): 67.     CrossRef
• Indirect comparison of efficacy and safety of insulin glargine/lixisenatide and insulin degludec/insulin aspart in type 2 diabetes patients not controlled on basal insulin
  Anwar Ali Jammah
  Primary Care Diabetes.2020;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Cell metabolism pathways involved in the pathophysiological changes of diabetic peripheral neuropathy
  Yaowei Lv, Xiangyun Yao, Xiao Li, Yuanming Ouyang, Cunyi Fan, Yun Qian
  Neural Regeneration Research.2024; 19(3): 598.     CrossRef
• Diyabet Tedavisinde Antioksidan Etki: Alfa Lipoik Asit
  Umut DALMIŞ, Emine Merve EKİCİ
  Avrasya Sağlık Bilimleri Dergisi.2024; 7(1): 68.     CrossRef
• Ranking Alpha Lipoic Acid and Gamma Linolenic Acid in Terms of Efficacy and Safety in the Management of Adults With Diabetic Peripheral Neuropathy: A Systematic Review and Network Meta-analysis
  Mario B. Prado, Karen Joy B. Adiao
  Canadian Journal of Diabetes.2024;[Epub]     CrossRef
• Comprehensive comparison of a new technology with traditional methods for extracting Ougan (Citrus reticulata cv. Suavissima) seed oils: Physicochemical properties, fatty acids, functional components, and antioxidant activities
  Huaxia Yang, Yudan Lin, Xiaoxu Zhu, Haishuo Mu, Yi Li, Shuangyang Chen, Jia Li, Xuedan Cao
  LWT.2024; 197: 115857.     CrossRef
• Genetic and Transcriptomic Background of Oxidative Stress and Antioxidative Therapies in Late Complications of Type 2 Diabetes Mellitus: A Systematic Review
  Gašper Tonin, Vita Dolžan, Jasna Klen
  Antioxidants.2024; 13(3): 277.     CrossRef
• Alpha-lipoic acid activates AMPK to protect against oxidative stress and apoptosis in rats with diabetic peripheral neuropathy
  Tianya Zhang, Dong Zhang, Zhihong Zhang, Jiaxin Tian, Jingwen An, Wang Zhang, Ying Ben
  Hormones.2023; 22(1): 95.     CrossRef
• Pathogenetic treatments for diabetic peripheral neuropathy
  Dan Ziegler
  Diabetes Research and Clinical Practice.2023; 206: 110764.     CrossRef
• Omega-3 Nutrition Therapy for the Treatment of Diabetic Sensorimotor Polyneuropathy
  Deepak Menon, Evan J. H. Lewis, Bruce A. Perkins, Vera Bril
  Current Diabetes Reviews.2022;[Epub]     CrossRef
• Effect of Alpha-Lipoic Acid in the Treatment of Diabetic Neuropathy: A Systematic Review
  Saleh A Abubaker, Abdulaziz M Alonazy, Albasseet Abdulrahman
  Cureus.2022;[Epub]     CrossRef
• Insight into the possible mechanism(s) involved in the antinociceptive and antineuropathic activity of Descurainia sophia L. Webb ex Prantl essential oil
  Donya Ziafatdoost Abed, Sajjad Jabbari, Zainul Amiruddin Zakaria, Saeed Mohammadi
  Journal of Ethnopharmacology.2022; 298: 115638.     CrossRef
• A novel approach to alpha-lipoic acid therapy in the treatment of diabetic peripheral neuropathy
  Alicja Sementina, Mateusz Cierzniakowski, Julia Rogalska, Izabela Piechowiak, Marek Spichalski, Aleksandra Araszkiewicz
  Journal of Medical Science.2022; : e714.     CrossRef
• Pathogenesis and Treatment of Diabetic Peripheral Neuropathy
  Seon Mee Kang
  The Journal of Korean Diabetes.2022; 23(4): 222.     CrossRef
• Diabetic Neuropathy: a Critical, Narrative Review of Published Data from 2019
  Ameet S. Nagpal, Jennifer Leet, Kaitlyn Egan, Rudy Garza
  Current Pain and Headache Reports.2021;[Epub]     CrossRef
• Therapeutic Potential of Ursolic Acid in Cancer and Diabetic Neuropathy Diseases
  Manzar Alam, Sabeeha Ali, Sarfraz Ahmed, Abdelbaset Mohamed Elasbali, Mohd Adnan, Asimul Islam, Md. Imtaiyaz Hassan, Dharmendra Kumar Yadav
  International Journal of Molecular Sciences.2021; 22(22): 12162.     CrossRef
• Diagnosis and treatment of the early stages of diabetic polyneuropathy
  V. N. Khramilin, A. N. Zavyalov, I. Yu. Demidova
  Meditsinskiy sovet = Medical Council.2020; (7): 56.     CrossRef

Citations

Citations to this article as recorded by  

• Acute kidney injury: a strong risk factor for hypoglycaemia in hospitalized patients with type 2 diabetes
  Ana Carreira, Pedro Castro, Filipe Mira, Miguel Melo, Pedro Ribeiro, Lèlita Santos
  Acta Diabetologica.2023; 60(9): 1179.     CrossRef
• Adherence to healthy lifestyle behaviors as a preventable risk factor for severe hypoglycemia in people with type 2 diabetes: A longitudinal nationwide cohort study
  Jae‐Seung Yun, Kyungdo Han, Yong‐Moon Park, Eugene Han, Yong‐ho Lee, Seung‐Hyun Ko
  Journal of Diabetes Investigation.2022; 13(9): 1533.     CrossRef
• Predicting hypoglycemia in hospitalized patients with diabetes: A derivation and validation study
  Michal Elbaz, Jeries Nashashibi, Shiri Kushnir, Leonard Leibovici
  Diabetes Research and Clinical Practice.2021; 171: 108611.     CrossRef
• Hospital care: improving outcomes in type 1 diabetes
  Schafer Boeder, Kristen Kulasa
  Current Opinion in Endocrinology, Diabetes & Obesity.2021; 28(1): 14.     CrossRef
• Data Pseudonymization in a Range That Does Not Affect Data Quality: Correlation with the Degree of Participation of Clinicians
  Soo-Yong Shin, Hun-Sung Kim
  Journal of Korean Medical Science.2021;[Epub]     CrossRef
• Letter: Differences in Clinical Outcomes between Patients with and without Hypoglycemia during Hospitalization: A Retrospective Study Using Real-World Evidence (Diabetes Metab J 2020;44:555-65)
  Sung-Woo Kim
  Diabetes & Metabolism Journal.2020; 44(5): 775.     CrossRef
• Response: Differences in Clinical Outcomes between Patients with and without Hypoglycemia during Hospitalization: A Retrospective Study Using Real-World Evidence (Diabetes Metab J 2020;44:555-65)
  Jeongmin Lee, Hun-Sung Kim
  Diabetes & Metabolism Journal.2020; 44(5): 779.     CrossRef
• Hypoglycaemia and Cardiovascular Disease Risk in Patients with Diabetes
  Niki Katsiki, Kalliopi Kotsa, Anca P. Stoian, Dimitri P. Mikhailidis
  Current Pharmaceutical Design.2020; 26(43): 5637.     CrossRef

Citations

Citations to this article as recorded by  

• Fibroblast growth factor 21 alleviates unilateral ureteral obstruction-induced renal fibrosis by inhibiting Wnt/β-catenin signaling pathway
  Wenhui Zhong, Yuheng Jiang, Huizhen Wang, Xiang Luo, Tao Zeng, Huimi Huang, Ling Xiao, Nan Jia, Aiqing Li
  Biochimica et Biophysica Acta (BBA) - Molecular Cell Research.2024; 1871(2): 119620.     CrossRef
• Urinary Excretion of Biomolecules Related to Cell Cycle, Proliferation, and Autophagy in Subjects with Type 2 Diabetes and Chronic Kidney Disease
  Anton I. Korbut, Vyacheslav V. Romanov, Vadim V. Klimontov
  Biomedicines.2024; 12(3): 487.     CrossRef
• New developments in the biology of fibroblast growth factors
  David M. Ornitz, Nobuyuki Itoh
  WIREs Mechanisms of Disease.2022;[Epub]     CrossRef
• SIRT1–SIRT7 in Diabetic Kidney Disease: Biological Functions and Molecular Mechanisms
  Wenxiu Qi, Cheng Hu, Daqing Zhao, Xiangyan Li
  Frontiers in Endocrinology.2022;[Epub]     CrossRef
• Research Progress of Fibroblast Growth Factor 21 in Fibrotic Diseases
  Min-Qi Jia, Cha-Xiang Guan, Jia-Hao Tao, Yong Zhou, Liang-Jun Yan
  Oxidative Medicine and Cellular Longevity.2022; 2022: 1.     CrossRef
• Metabolic-associated fatty liver disease increases the risk of end-stage renal disease in patients with biopsy-confirmed diabetic nephropathy: a propensity-matched cohort study
  Yutong Zou, Lijun Zhao, Junlin Zhang, Yiting Wang, Yucheng Wu, Honghong Ren, Tingli Wang, Yuancheng Zhao, Huan Xu, Lin Li, Nanwei Tong, Fang Liu
  Acta Diabetologica.2022; 60(2): 225.     CrossRef
• FGF21 and Chronic Kidney Disease
  João Victor Salgado, Miguel Angelo Goes, Natalino Salgado Filho
  Metabolism.2021; 118: 154738.     CrossRef
• The Multiple Roles of Fibroblast Growth Factor in Diabetic Nephropathy
  Junyu Deng, Ye Liu, Yiqiu Liu, Wei Li, Xuqiang Nie
  Journal of Inflammation Research.2021; Volume 14: 5273.     CrossRef
• Therapeutic effect and mechanism of combined use of FGF21 and insulin on diabetic nephropathy
  Fanrui Meng, Yukai Cao, Mir Hassan Khoso, Kai Kang, Guiping Ren, Wei Xiao, Deshan Li
  Archives of Biochemistry and Biophysics.2021; 713: 109063.     CrossRef
• FGF19 and FGF21 for the Treatment of NASH—Two Sides of the Same Coin? Differential and Overlapping Effects of FGF19 and FGF21 From Mice to Human
  Emma Henriksson, Birgitte Andersen
  Frontiers in Endocrinology.2020;[Epub]     CrossRef
• FGF21: An Emerging Therapeutic Target for Non-Alcoholic Steatohepatitis and Related Metabolic Diseases
  Erik J. Tillman, Tim Rolph
  Frontiers in Endocrinology.2020;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Interplay of lipid metabolism and inflammation in podocyte injury
  Zilv Luo, Zhaowei Chen, Jijia Hu, Guohua Ding
  Metabolism.2024; 150: 155718.     CrossRef
• Associations of plasma sphingolipids with measures of insulin sensitivity, β-cell function, and incident diabetes in Japanese Americans
  Ji Cheol Bae, Pandora L. Wander, Rozenn N. Lemaitre, Amanda M. Fretts, Colleen M. Sitlani, Hai H. Bui, Melissa K. Thomas, Donna Leonetti, Wilfred Y. Fujimoto, Edward J. Boyko, Kristina M. Utzschneider
  Nutrition, Metabolism and Cardiovascular Diseases.2024; 34(3): 633.     CrossRef
• A review of the mechanisms of abnormal ceramide metabolism in type 2 diabetes mellitus, Alzheimer’s disease, and their co-morbidities
  Yun Pan, Jieying Li, Panjie Lin, Lihua Wan, Yiqian Qu, Lingyong Cao, Lei Wang
  Frontiers in Pharmacology.2024;[Epub]     CrossRef
• Ceramides and mitochondrial homeostasis
  Song Ding, Guorui Li, Tinglv Fu, Tianyu Zhang, Xiao Lu, Ning Li, Qing Geng
  Cellular Signalling.2024; 117: 111099.     CrossRef
• Reduced sphingolipid biosynthesis modulates proteostasis networks to enhance longevity
  Nathaniel L. Hepowit, Eric Blalock, Sangderk Lee, Kimberly M. Bretland, Jason A. MacGurn, Robert C. Dickson
  Aging.2023; 15(2): 472.     CrossRef
• Protective effect of natural products in the metabolic-associated kidney diseases via regulating mitochondrial dysfunction
  Peng Liu, Yao Chen, Jing Xiao, Wenhui Zhu, Xiaoming Yan, Ming Chen
  Frontiers in Pharmacology.2023;[Epub]     CrossRef
• BCAA insufficiency leads to premature ovarian insufficiency via ceramide‐induced elevation of ROS
  Xiao Guo, Yuemeng Zhu, Lu Guo, Yiwen Qi, Xiaocheng Liu, Jinhui Wang, Jiangtao Zhang, Linlin Cui, Yueyang Shi, Qichu Wang, Cenxi Liu, Guangxing Lu, Yilian Liu, Tao Li, Shangyu Hong, Yingying Qin, Xuelian Xiong, Hao Wu, Lin Huang, He Huang, Chao Gu, Bin Li,
  EMBO Molecular Medicine.2023;[Epub]     CrossRef
• Chinese herbal medicine and its active compounds in attenuating renal injury via regulating autophagy in diabetic kidney disease
  Peng Liu, Wenhui Zhu, Yang Wang, Guijie Ma, Hailing Zhao, Ping Li
  Frontiers in Endocrinology.2023;[Epub]     CrossRef
• Integrated gas chromatography‐mass spectrometry and ultra‐high‐performance liquid chromatography‐mass spectrometry renal metabolomics and lipidomics deciphered the metabolic regulation mechanism of Gushudan on kidney‐yang‐deficiency‐syndrome rats
  Qing Lu, Jing Zhang, Ling Xin, Yanwei Lou, Feng Qin, Longshan Zhao, Zhili Xiong
  Journal of Separation Science.2023;[Epub]     CrossRef
• Advances in the pharmacological study of Chinese herbal medicine to alleviate diabetic nephropathy by improving mitochondrial oxidative stress
  Ming Chen, Yao Chen, Wenhui Zhu, Xiaoming Yan, Jing Xiao, Peiqing Zhang, Peng Liu, Ping Li
  Biomedicine & Pharmacotherapy.2023; 165: 115088.     CrossRef
• Rodent models to study type 1 and type 2 diabetes induced human diabetic nephropathy
  Amit Talukdar, Mandira Basumatary
  Molecular Biology Reports.2023; 50(9): 7759.     CrossRef
• Art2 mediates selective endocytosis of methionine transporters during adaptation to sphingolipid depletion
  Nathaniel L. Hepowit, Bradley Moon, Adam C. Ebert, Robert C. Dickson, Jason A. MacGurn
  Journal of Cell Science.2023;[Epub]     CrossRef
• Kidney lipid dysmetabolism and lipid droplet accumulation in chronic kidney disease
  Alla Mitrofanova, Sandra Merscher, Alessia Fornoni
  Nature Reviews Nephrology.2023; 19(10): 629.     CrossRef
• Research progress of autophagy in pathogenesis of diabetes nephropathy
  Shengnan Zeng, Ying Li
  Diabetic Nephropathy.2023; 3(3): 51.     CrossRef
• Lipidomic approaches to dissect dysregulated lipid metabolism in kidney disease
  Judy Baek, Chenchen He, Farsad Afshinnia, George Michailidis, Subramaniam Pennathur
  Nature Reviews Nephrology.2022; 18(1): 38.     CrossRef
• Podocyte Bioenergetics in the Development of Diabetic Nephropathy: The Role of Mitochondria
  Irena Audzeyenka, Agnieszka Bierżyńska, Abigail C Lay
  Endocrinology.2022;[Epub]     CrossRef
• Acylcarnitines: Can They Be Biomarkers of Diabetic Nephropathy?
  Xiaodie Mu, Min Yang, Peiyao Ling, Aihua Wu, Hua Zhou, Jingting Jiang
  Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2022; Volume 15: 247.     CrossRef
• Research Progress on Natural Products’ Therapeutic Effects on Atrial Fibrillation by Regulating Ion Channels
  Jinshan He, Sicong Li, Yumeng Ding, Yujia Tong, Xuebin Li, Simona Saponara
  Cardiovascular Therapeutics.2022; 2022: 1.     CrossRef
• Mechanisms of podocyte injury and implications for diabetic nephropathy
  Federica Barutta, Stefania Bellini, Gabriella Gruden
  Clinical Science.2022; 136(7): 493.     CrossRef
• A Rheostat of Ceramide and Sphingosine-1-Phosphate as a Determinant of Oxidative Stress-Mediated Kidney Injury
  Norishi Ueda
  International Journal of Molecular Sciences.2022; 23(7): 4010.     CrossRef
• Implications of Sphingolipid Metabolites in Kidney Diseases
  Shamroop kumar Mallela, Sandra Merscher, Alessia Fornoni
  International Journal of Molecular Sciences.2022; 23(8): 4244.     CrossRef
• Role of ceramides in the pathogenesis of diabetes mellitus and its complications
  Nawajes Mandal, Richard Grambergs, Koushik Mondal, Sandip K. Basu, Faiza Tahia, Sam Dagogo-Jack
  Journal of Diabetes and its Complications.2021; 35(2): 107734.     CrossRef
• Rotten to the Cortex: Ceramide-Mediated Lipotoxicity in Diabetic Kidney Disease
  Rebekah J. Nicholson, Marcus G. Pezzolesi, Scott A. Summers
  Frontiers in Endocrinology.2021;[Epub]     CrossRef
• Enhancing lifespan of budding yeast by pharmacological lowering of amino acid pools
  Nathaniel L. Hepowit, Jessica K. A. Macedo, Lyndsay E. A. Young, Ke Liu, Ramon C. Sun, Jason A. MacGurn, Robert C. Dickson
  Aging.2021; 13(6): 7846.     CrossRef
• New insights into renal lipid dysmetabolism in diabetic kidney disease
  Alla Mitrofanova, George Burke, Sandra Merscher, Alessia Fornoni
  World Journal of Diabetes.2021; 12(5): 524.     CrossRef
• Excessively Enlarged Mitochondria in the Kidneys of Diabetic Nephropathy
  Kiyoung Kim, Eun-Young Lee
  Antioxidants.2021; 10(5): 741.     CrossRef
• Mechanistic insights into the role of serum-glucocorticoid kinase 1 in diabetic nephropathy: A systematic review
  Saba Noor, Taj Mohammad, Gulam M. Ashraf, Joviana Farhat, Anwar L. Bilgrami, Mathew Suji Eapen, Sukhwinder Singh Sohal, Dharmendra Kumar Yadav, Md Imtaiyaz Hassan
  International Journal of Biological Macromolecules.2021; 193: 562.     CrossRef
• The Updates of Podocyte Lipid Metabolism in Proteinuric Kidney Disease
  Yu Sun, Sijia Cui, Yunfeng Hou, Fan Yi
  Kidney Diseases.2021; 7(6): 438.     CrossRef
• Saturated fatty acids induce insulin resistance in podocytes through inhibition of IRS1 via activation of both IKKβ and mTORC1
  Benoit Denhez, Marina Rousseau, Crysta Spino, David-Alexandre Dancosst, Marie-Ève Dumas, Andréanne Guay, Farah Lizotte, Pedro Geraldes
  Scientific Reports.2020;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Association between underweight and risk of heart failure in diabetes patients
  Tae Kyung Yoo, Kyung‐Do Han, Eun‐Jung Rhee, Won‐Young Lee
  Journal of Cachexia, Sarcopenia and Muscle.2024; 15(2): 671.     CrossRef
• Big Data Research in the Field of Endocrine Diseases Using the Korean National Health Information Database
  Sun Wook Cho, Jung Hee Kim, Han Seok Choi, Hwa Young Ahn, Mee Kyoung Kim, Eun Jung Rhee
  Endocrinology and Metabolism.2023; 38(1): 10.     CrossRef
• Research on obesity using the National Health Information Database: recent trends
  Eun-Jung Rhee
  Cardiovascular Prevention and Pharmacotherapy.2023; 5(2): 35.     CrossRef
• Impact of mental disorders on the risk of heart failure among Korean patients with diabetes: a cohort study
  Tae Kyung Yoo, Kyung-Do Han, Eun-Jung Rhee, Won-Young Lee
  Cardiovascular Diabetology.2023;[Epub]     CrossRef
• Differential Impact of Obesity on the Risk of Diabetes Development in Two Age Groups: Analysis from the National Health Screening Program
  Tae Kyung Yoo, Kyung-Do Han, Yang-Hyun Kim, Ga Eun Nam, Sang Hyun Park, Eun-Jung Rhee, Won-Young Lee
  Diabetes & Metabolism Journal.2023; 47(6): 846.     CrossRef
• Characterization of the oxidative stress and inflammatory markers in metabolically healthy obese individuals
  Hazhmat Ali
  Al-Kufa University Journal for Biology.2023; 15(3): 28.     CrossRef
• The Influence of Obesity and Metabolic Health on Vascular Health
  Eun-Jung Rhee
  Endocrinology and Metabolism.2022; 37(1): 1.     CrossRef
• Changes in Patterns of Physical Activity and Risk of Heart Failure in Newly Diagnosed Diabetes Mellitus Patients
  Inha Jung, Hyemi Kwon, Se Eun Park, Kyung-Do Han, Yong-Gyu Park, Eun-Jung Rhee, Won-Young Lee
  Diabetes & Metabolism Journal.2022; 46(2): 327.     CrossRef
• Evaluating Triglyceride and Glucose Index as a Simple and Easy-to-Calculate Marker for All-Cause and Cardiovascular Mortality
  Kyung-Soo Kim, Sangmo Hong, You-Cheol Hwang, Hong-Yup Ahn, Cheol-Young Park
  Journal of General Internal Medicine.2022; 37(16): 4153.     CrossRef
• Impact of hypoglycemia at the time of hospitalization for heart failure from emergency department on major adverse cardiovascular events in patients with and without type 2 diabetes
  Seon-Ah Cha, Jae-Seung Yun, Gee-Hee Kim, Yu-Bae Ahn
  Cardiovascular Diabetology.2022;[Epub]     CrossRef
• Insulin resistance and heart failure with preserved ejection fraction. Pathogenetic and therapeutic crossroads
  O. V. Tsygankova, N. E. Evdokimova, V. V. Veretyuk, L. D. Latyntseva, A. S. Ametov
  Diabetes mellitus.2022; 25(6): 535.     CrossRef
• The association between metabolic syndrome and heart failure in middle-aged male and female: Korean population-based study of 2 million individuals
  Tae-Eun Kim, Hyeongsu Kim, JiDong Sung, Duk-Kyung Kim, Myoung-Soon Lee, Seong Woo Han, Hyun-Joong Kim, Sung Hea Kim, Kyu-Hyung Ryu
  Epidemiology and Health.2022; 44: e2022078.     CrossRef
• Diabetes and Heart Failure
  Eun-Jung Rhee
  The Journal of Korean Diabetes.2021; 22(1): 12.     CrossRef
• Prediabetes and the risk of heart failure: A meta‐analysis
  Xiaoyan Cai, Xiong Liu, Lichang Sun, Yiting He, Sulin Zheng, Yang Zhang, Yuli Huang
  Diabetes, Obesity and Metabolism.2021; 23(8): 1746.     CrossRef
• Diabetes and Heart Failure
  Eun-Jung Rhee
  Cardiovascular Prevention and Pharmacotherapy.2021; 3(2): 21.     CrossRef
• Effects of Lipid Overload on Heart in Metabolic Diseases
  An Yan, Guinan Xie, Xinya Ding, Yi Wang, Liping Guo
  Hormone and Metabolic Research.2021; 53(12): 771.     CrossRef
• Obesity Degree and Glycemic Status: Factors That Should Be Considered in Heart Failure
  Hye Soon Kim
  Diabetes & Metabolism Journal.2020; 44(4): 529.     CrossRef
• Letter: Associations among Obesity Degree, Glycemic Status, and Risk of Heart Failure in 9,720,220 Korean Adults (Diabetes Metab J 2020;44:592-601)
  Darae Kim
  Diabetes & Metabolism Journal.2020; 44(5): 777.     CrossRef
• Response: Associations among Obesity Degree, Glycemic Status, and Risk of Heart Failure in 9,720,220 Korean Adults (Diabetes Metab J 2020;44:592-601)
  Eun-Jung Rhee, Won-Young Lee
  Diabetes & Metabolism Journal.2020; 44(5): 781.     CrossRef

Citations

Citations to this article as recorded by  

• Potential use of sodium glucose co-transporter 2 inhibitors during acute illness: a systematic review based on COVID-19
  Carmen Tisch, Eleni Xourgia, Aristomenis Exadaktylos, Mairi Ziaka
  Endocrine.2024;[Epub]     CrossRef
• Insulin and Metformin Administration: Unravelling the Multifaceted Association with Mortality across Various Clinical Settings Considering Type 2 Diabetes Mellitus and COVID-19
  Łukasz Lewandowski, Agnieszka Bronowicka-Szydełko, Maciej Rabczyński, Dorota Bednarska-Chabowska, Joanna Adamiec-Mroczek, Adrian Doroszko, Małgorzata Trocha, Krzysztof Kujawa, Agnieszka Matera-Witkiewicz, Edwin Kuźnik, Paweł Lubieniecki, Marcin Madziarski
  Biomedicines.2024; 12(3): 605.     CrossRef
• Pre-admission use of sodium glucose transporter-2 inhibitor (SGLT-2i) may significantly improves Covid-19 outcomes in patients with diabetes: A systematic review, meta-analysis, and meta-regression
  Hikmat Permana, Theo Audi Yanto, Timotius Ivan Hariyanto
  Diabetes Research and Clinical Practice.2023; 195: 110205.     CrossRef
• Risk phenotypes of diabetes and association with COVID-19 severity and death: an update of a living systematic review and meta-analysis
  Sabrina Schlesinger, Alexander Lang, Nikoletta Christodoulou, Philipp Linnerz, Kalliopi Pafili, Oliver Kuss, Christian Herder, Manuela Neuenschwander, Janett Barbaresko, Michael Roden
  Diabetologia.2023; 66(8): 1395.     CrossRef
• Factors influencing the severity of COVID-19 course for patients with diabetes mellitus in tashkent: a retrospective cohort study
  A. V. Alieva, A. A. Djalilov, F. A. Khaydarova, A. V. Alimov, D. Z. Khalilova, V. A. Talenova, N. U. Alimova, M. D. Aripova, A. S. Sadikova
  Obesity and metabolism.2023; 20(2): 92.     CrossRef
• Pituitary Diseases and COVID-19 Outcomes in South Korea: A Nationwide Cohort Study
  Jeonghoon Ha, Kyoung Min Kim, Dong-Jun Lim, Keeho Song, Gi Hyeon Seo
  Journal of Clinical Medicine.2023; 12(14): 4799.     CrossRef
• Epidemiological features and consequences of COVID‐19 in patients with and without gastrointestinal symptoms in southwestern Iran. A retrospective observational study
  Habibollah Azarbakhsh, Leila Moftakhar, Aliasghar Valipour, Alireza Mirahmadizadeh, Hekmat Allah Moradi, Elahe Piraee
  Health Science Reports.2023;[Epub]     CrossRef
• The Impact of Long-Term Conditions and Comorbidity Patterns on COVID-19 Infection and Hospitalisation: A Cohort Study
  Yun-Ting Huang, Andrew Steptoe, Riyaz S. Patel, Esme Fuller Thomson, Dorina Cadar
  Gerontology.2023; 69(10): 1200.     CrossRef
• Association Between Anti-diabetic Agents and Clinical Outcomes of COVID-19 in Patients with Diabetes: A Systematic Review and Meta-Analysis
  Tiantian Han, Shaodi Ma, Chenyu Sun, Huimei Zhang, Guangbo Qu, Yue Chen, Ce Cheng, Eric L. Chen, Mubashir Ayaz Ahmed, Keun Young Kim, Raveena Manem, Mengshi Chen, Zhichun Guo, Hongru Yang, Yue Yan, Qin Zhou
  Archives of Medical Research.2022; 53(2): 186.     CrossRef
• Use of DPP4i reduced odds of clinical deterioration and hyperinflammatory syndrome in COVID-19 patients with type 2 diabetes: Propensity score analysis of a territory-wide cohort in Hong Kong
  Carlos K.H. Wong, David T.W. Lui, Angel Y.C. Lui, Ashley C.Y. Kwok, Marshall C.H. Low, Kristy T.K. Lau, Ivan C.H. Au, Xi Xiong, Matthew S.H. Chung, Eric H.Y. Lau, Benjamin J. Cowling
  Diabetes & Metabolism.2022; 48(1): 101307.     CrossRef
• Dipeptidyl peptidase-4 (DPP-IV) inhibitor was associated with mortality reduction in COVID-19 — A systematic review and meta-analysis
  Ahmad Fariz Malvi Zamzam Zein, Wilson Matthew Raffaello
  Primary Care Diabetes.2022; 16(1): 162.     CrossRef
• Prevalence and impact of diabetes in hospitalized COVID‐19 patients: A systematic review and meta‐analysis
  Sian A. Bradley, Maciej Banach, Negman Alvarado, Ivica Smokovski, Sonu M. M. Bhaskar
  Journal of Diabetes.2022; 14(2): 144.     CrossRef
• Interplay between Inflammaging, Frailty and Nutrition in Covid-19: Preventive and Adjuvant Treatment Perspectives
  A. Padilha de Lima, M. Macedo Rogero, T. Araujo Viel, H.M. Garay-Malpartida, I. Aprahamian, Sandra Maria Lima Ribeiro
  The Journal of nutrition, health and aging.2022; 26(1): 67.     CrossRef
• Increase in blood glucose level and incidence of diabetic ketoacidosis in children with type 1 diabetes mellitus in the Daegu-Gyeongbuk area during the coronavirus disease 2019 (COVID-19) pandemic: a retrospective cross-sectional study
  Mi Seon Lee, Rosie Lee, Cheol Woo Ko, Jung Eun Moon
  Journal of Yeungnam Medical Science.2022; 39(1): 46.     CrossRef
• Interrelationship between 2019-nCov receptor DPP4 and diabetes mellitus targets based on protein interaction network
  Qian Gao, Wenjun Zhang, Tingting Li, Guojun Yang, Wei Zhu, Naijun Chen, Huawei Jin
  Scientific Reports.2022;[Epub]     CrossRef
• Can sodium-glucose co-transporter-2 (SGLT-2) inhibitor reduce the risk of adverse complications due to COVID-19? – Targeting hyperinflammation
  Afnan Alshnbari, Iskandar Idris
  Current Medical Research and Opinion.2022; 38(3): 357.     CrossRef
• Commentary: Mortality Risk of Antidiabetic Agents for Type 2 Diabetes With COVID-19: A Systematic Review and Meta-Analysis
  Li-Min Zhao, Xie-Hui Chen, Mei Qiu
  Frontiers in Endocrinology.2022;[Epub]     CrossRef
• COVID-19 and Diabetes
  Awadhesh Kumar Singh, Kamlesh Khunti
  Annual Review of Medicine.2022; 73(1): 129.     CrossRef
• The enzymes in COVID-19: A review
  Maria Helena Menezes Estevam Alves, Layla Carvalho Mahnke, Tifany Cerqueira Macedo, Thais Ketinly dos Santos Silva, Luiz Bezerra Carvalho Junior
  Biochimie.2022; 197: 38.     CrossRef
• IMPACT OF ANTIDIABETIC DRUGS ON RISK AND OUTCOME OF COVID-19 INFECTION: A REVIEW
  Adnan A. Zainal, Marwan M. Merkhan
  Military Medical Science Letters.2022; 91(2): 140.     CrossRef
• Does metformin affect outcomes in COVID‐19 patients with new or pre‐existing diabetes mellitus? A systematic review and meta‐analysis
  Adithan Ganesh, Michael D. Randall
  British Journal of Clinical Pharmacology.2022; 88(6): 2642.     CrossRef
• Diabetes, Metformin and the Clinical Course of Covid-19: Outcomes, Mechanisms and Suggestions on the Therapeutic Use of Metformin
  Clifford J. Bailey, Mike Gwilt
  Frontiers in Pharmacology.2022;[Epub]     CrossRef
• The Role of Diabetes and Hyperglycemia on COVID-19 Infection Course—A Narrative Review
  Evangelia Tzeravini, Eleftherios Stratigakos, Chris Siafarikas, Anastasios Tentolouris, Nikolaos Tentolouris
  Frontiers in Clinical Diabetes and Healthcare.2022;[Epub]     CrossRef
• Preadmission use of antidiabetic medications and mortality among patients with COVID-19 having type 2 diabetes: A meta-analysis
  Nam Nhat Nguyen, Dung Si Ho, Hung Song Nguyen, Dang Khanh Ngan Ho, Hung-Yuan Li, Chia-Yuan Lin, Hsiao-Yean Chiu, Yang-Ching Chen
  Metabolism.2022; 131: 155196.     CrossRef
• Glucose-Lowering Agents and COVID-19
  Ah Reum Khang
  The Journal of Korean Diabetes.2022; 23(1): 1.     CrossRef
• Impact of diabetes on COVID‐19 mortality and hospital outcomes from a global perspective: An umbrella systematic review and meta‐analysis
  Stavroula Kastora, Manisha Patel, Ben Carter, Mirela Delibegovic, Phyo Kyaw Myint
  Endocrinology, Diabetes & Metabolism.2022;[Epub]     CrossRef
• The Association Between Antidiabetic Agents and Clinical Outcomes of COVID-19 Patients With Diabetes: A Bayesian Network Meta-Analysis
  Yidan Chen, Xingfei Lv, Sang Lin, Mohammad Arshad, Mengjun Dai
  Frontiers in Endocrinology.2022;[Epub]     CrossRef
• Renin‐Angiotensin Aldosterone System Inhibitors and COVID‐19: A Systematic Review and Meta‐Analysis Revealing Critical Bias Across a Body of Observational Research
  Jordan Loader, Frances C. Taylor, Erik Lampa, Johan Sundström
  Journal of the American Heart Association.2022;[Epub]     CrossRef
• Diabetes and SARS-CoV-2–Is There a Mutual Connection?
  Anna P. Jedrzejak, Edyta K. Urbaniak, Jadwiga A. Wasko, Natalia Ziojla, Malgorzata Borowiak
  Frontiers in Cell and Developmental Biology.2022;[Epub]     CrossRef
• The relationship of age, sex and prothrombin time related to the severity and mortality of COVID-19 patients with diabetes mellitus: a systematic review and meta analysis
  Audrey Fabianisa Mirza, Ceria Halim, Mutiara Indah Sari
  F1000Research.2022; 11: 729.     CrossRef
• Are lipid ratios and triglyceride-glucose index associated with critical care outcomes in COVID-19 patients?
  Marzieh Rohani-Rasaf, Kosar Mirjalili, Akram Vatannejad, Maryam Teimouri, Xiao-Feng Yang
  PLOS ONE.2022; 17(8): e0272000.     CrossRef
• Early glycaemic variability increases 28-day mortality and prolongs intensive care unit stay in critically ill patients with pneumonia
  Seong Ho Kim, Ji Young Kim, Eun Song Kim, Il Rae Park, Eun Yeong Ha, Seung Min Chung, Jun Sung Moon, Ji Sung Yoon, Kyu Chang Won, Hyoung Woo Lee
  Annals of Medicine.2022; 54(1): 2724.     CrossRef
• Dipeptidyl peptidase 4 inhibitors in COVID-19: Beyond glycemic control
  Niya Narayanan, Dukhabandhu Naik, Jayaprakash Sahoo, Sadishkumar Kamalanathan
  World Journal of Virology.2022; 11(6): 399.     CrossRef
• Prevalencia de secuelas en pacientes con diabetes mellitus tipo 2 sobrevivientes al COVID-19
  Gianela M. Cancino-Castillo, Miguel A. Tresierra-Ayala, Jorge L. Campos-Reyna, Jaime Rosales-Rimache
  REVISTA MÉDICA VALLEJIANA/ Vallejian Medical Journal.2022; 11(2): 48.     CrossRef
• Predictors of adverse in-hospital outcome and recovery in patients with diabetes mellitus and COVID-19 pneumonia in Iraq
  Hussein Nafakhi, Mohammed Alareedh, Karrar Al-Buthabhak, Foaad Shaghee, Ahmed Nafakhi, Samet Kasim
  Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2021; 15(1): 33.     CrossRef
• Non-insulin anti-diabetic agents in patients with type 2 diabetes and COVID-19: A Critical Appraisal of Literature
  Awadhesh Kumar Singh, Ritu Singh, Banshi Saboo, Anoop Misra
  Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2021; 15(1): 159.     CrossRef
• COVID-19 associated with diabetes and other noncommunicable diseases led to a global health crisis
  Mark Thomaz Ugliara Barone, Belinda Ngongo, Simone Bega Harnik, Lucas Xavier de Oliveira, Dániel Végh, Patrícia Vieira de Luca, Hermelinda Cordeiro Pedrosa, Franco Giraudo, Roque Cardona-Hernandez, Nayanjeet Chaudhury, Luiz Menna-Barreto
  Diabetes Research and Clinical Practice.2021; 171: 108587.     CrossRef
• A meta-analysis on the preadmission use of DPP-4 inhibitors and risk of a fatal or severe course of illness in patients with COVID-19
  Chia Siang Kow, Syed Shahzad Hasan
  Therapies.2021; 76(4): 361.     CrossRef
• Disentangling conflicting evidence on DPP-4 inhibitors and outcomes of COVID-19: narrative review and meta-analysis
  B. M. Bonora, A. Avogaro, G. P. Fadini
  Journal of Endocrinological Investigation.2021; 44(7): 1379.     CrossRef
• Prognostic bioindicators in severe COVID-19 patients
  L. Bergantini, E. Bargagli, M. d'Alessandro, R.M. Refini, P. Cameli, L. Galasso, C. Scapellato, F. Montagnani, S. Scolletta, F. Franchi, S. Valente, D. Bennett, G. Sebastiani, B. Frediani, F. Dotta
  Cytokine.2021; 141: 155455.     CrossRef
• Epidemiological characteristics and outcomes of COVID-19 in diabetic versus non-diabetic patients
  Leila Moftakhar, Parisa Moftakhar, Elahe Piraee, Haleh Ghaem, Aliasghar Valipour, Habibollah Azarbakhsh
  International Journal of Diabetes in Developing Countries.2021; 41(3): 383.     CrossRef
• DPP-4 inhibition and COVID-19: From initial concerns to recent expectations
  André J. Scheen
  Diabetes & Metabolism.2021; 47(2): 101213.     CrossRef
• Use of dipeptidyl peptidase‐4 inhibitors and prognosis of COVID‐19 in hospitalized patients with type 2 diabetes: A propensity score analysis from the CORONADO study
  Ronan Roussel, Patrice Darmon, Matthieu Pichelin, Thomas Goronflot, Yawa Abouleka, Leila Ait Bachir, Ingrid Allix, Deborah Ancelle, Sara Barraud, Lyse Bordier, Aurélie Carlier, Nicolas Chevalier, Christine Coffin‐Boutreux, Emmanuel Cosson, Anne Dorange, O
  Diabetes, Obesity and Metabolism.2021; 23(5): 1162.     CrossRef
• Dipeptidyl peptidase-4 inhibitor use and mortality in COVID-19 patients with diabetes mellitus: an updated systematic review and meta-analysis
  Rimesh Pal, Mainak Banerjee, Soham Mukherjee, Ranjitpal Singh Bhogal, Amanpreet Kaur, Sanjay K. Bhadada
  Therapeutic Advances in Endocrinology and Metabolism.2021; 12: 204201882199648.     CrossRef
• Renin–angiotensin-system inhibitors and all-cause mortality in patients with COVID-19: a systematic review and meta-analysis of observational studies
  Chirag Bavishi, Paul K. Whelton, Giuseppe Mancia, Giovanni Corrao, Franz H. Messerli
  Journal of Hypertension.2021; 39(4): 784.     CrossRef
• Evaluation of the Current Therapeutic Approaches for COVID-19: A Systematic Review and a Meta-analysis
  Zeinab Abdelrahman, Qian Liu, Shanmei Jiang, Mengyuan Li, Qingrong Sun, Yue Zhang, Xiaosheng Wang
  Frontiers in Pharmacology.2021;[Epub]     CrossRef
• Dipeptidyl peptidase 4 (DPP4) inhibitor and outcome from coronavirus disease 2019 (COVID-19) in diabetic patients: a systematic review, meta-analysis, and meta-regression
  Timotius Ivan Hariyanto, Andree Kurniawan
  Journal of Diabetes & Metabolic Disorders.2021; 20(1): 543.     CrossRef
• Impact of diabetes mellitus on in-hospital mortality in adult patients with COVID-19: a systematic review and meta-analysis
  Halla Kaminska, Lukasz Szarpak, Dariusz Kosior, Wojciech Wieczorek, Agnieszka Szarpak, Mahdi Al-Jeabory, Wladyslaw Gawel, Aleksandra Gasecka, Milosz J. Jaguszewski, Przemyslawa Jarosz-Chobot
  Acta Diabetologica.2021; 58(8): 1101.     CrossRef
• Dipeptidyl peptidase-4 (DPP-4) inhibitor and mortality in coronavirus disease 2019 (COVID-19) – A systematic review, meta-analysis, and meta-regression
  Iis Inayati Rakhmat, Yudith Yunia Kusmala, Dewi Ratih Handayani, Henny Juliastuti, Eka Noneng Nawangsih, Arief Wibowo, Michael Anthonius Lim, Raymond Pranata
  Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2021; 15(3): 777.     CrossRef
• Post-infection depressive, anxiety and post-traumatic stress symptoms: A prospective cohort study in patients with mild COVID-19
  Flavia Ismael, João C.S. Bizario, Tatiane Battagin, Beatriz Zaramella, Fabio E. Leal, Julio Torales, Antonio Ventriglio, Megan E. Marziali, Silvia S. Martins, João M. Castaldelli-Maia
  Progress in Neuro-Psychopharmacology and Biological Psychiatry.2021; 111: 110341.     CrossRef
• Managing diabetes in diabetic patients with COVID: where do we start from?
  Angelo Avogaro, Benedetta Bonora, Gian Paolo Fadini
  Acta Diabetologica.2021; 58(11): 1441.     CrossRef
• Is diabetes mellitus a wrongdoer to COVID-19 severity?
  Sanjib Sarkar, Dibyendu Das, Sawlang Borsingh Wann, Jatin Kalita, Prasenjit Manna
  Diabetes Research and Clinical Practice.2021; 178: 108936.     CrossRef
• Dipeptidyl Peptidase 4 Inhibitor, an Update
  Ju Hee Lee
  The Journal of Korean Diabetes.2021; 22(2): 91.     CrossRef
• Correlation Analysis Between Serum Uric Acid, Prealbumin Level, Lactate Dehydrogenase, and Severity of COVID-19
  Zhenmu Jin, Mo Zheng, Jichan Shi, Xinchun Ye, Fang Cheng, Que-Lu Chen, Jianping Huang, Xian-Gao Jiang
  Frontiers in Molecular Biosciences.2021;[Epub]     CrossRef
• Association Between Glucagon-Like Peptide 1 Receptor Agonist and Sodium–Glucose Cotransporter 2 Inhibitor Use and COVID-19 Outcomes
  Anna R. Kahkoska, Trine Julie Abrahamsen, G. Caleb Alexander, Tellen D. Bennett, Christopher G. Chute, Melissa A. Haendel, Klara R. Klein, Hemalkumar Mehta, Joshua D. Miller, Richard A. Moffitt, Til Stürmer, Kajsa Kvist, John B. Buse, Tim Q. Duong
  Diabetes Care.2021; 44(7): 1564.     CrossRef
• The effect of metformin on mortality and severity in COVID-19 patients with diabetes mellitus
  Wenxing Yang, Xuehong Sun, Jun Zhang, Kui Zhang
  Diabetes Research and Clinical Practice.2021; 178: 108977.     CrossRef
• Renin‐Angiotensin Aldosterone System Inhibitors in Primary Prevention and COVID‐19
  Jordan Loader, Erik Lampa, Stefan Gustafsson, Thomas Cars, Johan Sundström
  Journal of the American Heart Association.2021;[Epub]     CrossRef
• Factors influencing on development of COVID-19 pneumonia and association with oral anti-diabetic drugs in hospitalized patients with diabetes mellitus
  Ayça Elibol, Didem Eren, Macide Deniz Erdoğan, Merve Elmaağaç, Oguzhan Sıtkı Dizdar, İlhami Çelik, Ali İhsan Günal
  Primary Care Diabetes.2021; 15(5): 806.     CrossRef
• Aging & COVID-19 susceptibility, disease severity, and clinical outcomes: The role of entangled risk factors
  Melina Farshbafnadi, Sara Kamali Zonouzi, Mohammadmahdi Sabahi, Mahsa Dolatshahi, Mohammad Hadi Aarabi
  Experimental Gerontology.2021; 154: 111507.     CrossRef
• Classical and Counter-Regulatory Renin–Angiotensin System: Potential Key Roles in COVID-19 Pathophysiology
  Moudhi Almutlaq, Abir Abdullah Alamro, Fayhan Alroqi, Tlili Barhoumi
  CJC Open.2021; 3(8): 1060.     CrossRef
• Metformin in Patients With COVID-19: A Systematic Review and Meta-Analysis
  Yin Li, Xue Yang, Peijing Yan, Tong Sun, Zhi Zeng, Sheyu Li
  Frontiers in Medicine.2021;[Epub]     CrossRef
• Pre-existing health conditions and severe COVID-19 outcomes: an umbrella review approach and meta-analysis of global evidence
  Marina Treskova-Schwarzbach, Laura Haas, Sarah Reda, Antonia Pilic, Anna Borodova, Kasra Karimi, Judith Koch, Teresa Nygren, Stefan Scholz, Viktoria Schönfeld, Sabine Vygen-Bonnet, Ole Wichmann, Thomas Harder
  BMC Medicine.2021;[Epub]     CrossRef
• COVID-19 Vaccination for Endocrine Patients: A Position Statement from the Korean Endocrine Society
  Cheol Ryong Ku, Kyong Yeun Jung, Chang Ho Ahn, Jun Sung Moon, Ju Hee Lee, Eun Heui Kim, Hyemi Kwon, Hee Kyung Kim, Sunghwan Suh, Sangmo Hong, Jeonghoon Ha, Eun Roh, Jin Hwa Kim, Mi-kyung Kim
  Endocrinology and Metabolism.2021; 36(4): 757.     CrossRef
• High Fibrosis-4 Index Is Related with Worse Clinical Outcome in Patients with Coronavirus Disease 2019 and Diabetes Mellitus: A Multicenter Observational Study
  Sung-Woo Kim, Jae-Han Jeon, Jun Sung Moon, Mi Kyung Kim
  Endocrinology and Metabolism.2021; 36(4): 800.     CrossRef
• Mortality Risk of Antidiabetic Agents for Type 2 Diabetes With COVID-19: A Systematic Review and Meta-Analysis
  Chengxia Kan, Yang Zhang, Fang Han, Qian Xu, Tongtong Ye, Ningning Hou, Xiaodong Sun
  Frontiers in Endocrinology.2021;[Epub]     CrossRef
• Analysis of influence of background therapy for comorbidities in the period before infection on the risk of the lethal COVID outcome. Data from the international ACTIV SARS-CoV-2 registry («Analysis of chronic non-infectious diseases dynamics after COVID-
  E. I. Tarlovskaya, A. G. Arutyunov, A. O. Konradi, Yu. M. Lopatin, A. P. Rebrov, S. N. Tereshchenko, A. I. Chesnikova, H. G. Hayrapetyan, A. P. Babin, I. G. Bakulin, N. V. Bakulina, L. A. Balykova, A. S. Blagonravova, M. V. Boldina, A. R. Vaisberg, A. S.
  Kardiologiia.2021; 61(9): 20.     CrossRef
• Association of clinical characteristics, antidiabetic and cardiovascular agents with diabetes mellitus and COVID-19: a 7-month follow-up cohort study
  Marzieh Pazoki, Fatemeh Chichagi, Azar Hadadi, Samira Kafan, Mahnaz Montazeri, Sina Kazemian, Arya Aminorroaya, Mehdi Ebrahimi, Haleh Ashraf, Mojgan Mirabdolhagh Hazaveh, Mohammad Reza Khajavi, Reza Shariat Moharari, Seyed Hamidreza Sharifnia, Shahrokh Ka
  Journal of Diabetes & Metabolic Disorders.2021; 20(2): 1545.     CrossRef
• COVID-19 and Diabetes: A Comprehensive Review of Angiotensin Converting Enzyme 2, Mutual Effects and Pharmacotherapy
  Lingli Xie, Ziying Zhang, Qian Wang, Yangwen Chen, Dexue Lu, Weihua Wu
  Frontiers in Endocrinology.2021;[Epub]     CrossRef
• Impact of Diabetes on COVID-19 Mortality and Hospital Outcomes, a Global Perspective: An ONTOP Systematic Review and Meta-Analysis
  Stavroula Kastora, Manisha Patel, Ben Carter, Mirela Delibegovic, Phyo Kyaw Myint
  SSRN Electronic Journal .2021;[Epub]     CrossRef
• Decision Trees: Predictions of Global Vulnerability to Coronavirus Outbreaks
  Moacir José da Silva
  SSRN Electronic Journal .2020;[Epub]     CrossRef
• The potential association between common comorbidities and severity and mortality of coronavirus disease 2019: A pooled analysis
  Liman Luo, Menglu Fu, Yuanyuan Li, Shuiqing Hu, Jinlan Luo, Zhihui Chen, Jing Yu, Wenhua Li, Ruolan Dong, Yan Yang, Ling Tu, Xizhen Xu
  Clinical Cardiology.2020; 43(12): 1478.     CrossRef
• The Effect of Metformin Consumption on Mortality in Hospitalized COVID-19 patients: a systematic review and meta-analysis
  Antonia Anna Lukito, Raymond Pranata, Joshua Henrina, Michael Anthonius Lim, Sherly Lawrensia, Ketut Suastika
  Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2020; 14(6): 2177.     CrossRef
• Risk Factors on the Progression to Clinical Outcomes of COVID-19 Patients in South Korea: Using National Data
  Seon-Rye Kim, Seoul-Hee Nam, Yu-Rin Kim
  International Journal of Environmental Research and Public Health.2020; 17(23): 8847.     CrossRef
• Clinical Outcomes of COVID-19 Patients with Type 2 Diabetes: A Population-Based Study in Korea
  Ji Hong You, Sang Ah Lee, Sung-Youn Chun, Sun Ok Song, Byung-Wan Lee, Dae Jung Kim, Edward J. Boyko
  Endocrinology and Metabolism.2020; 35(4): 901.     CrossRef

This study compared short-term walking outcomes in diabetic amputees after prosthesis fitting compared to that in non-diabetic amputees. We retrospectively investigated walking outcomes at 3 months after starting gait training with a prosthesis. Forty-four unilateral transtibial amputees with (n=18) and without diabetes (n=26) were included. At 3 months after gait training with a prosthesis, only 2/18 (11.1%) and 3/18 (16.7%) diabetic amputees were capable of independent outdoor and indoor walking without cane, respectively. However, 21/26 (80.8%) and 24/26 (92.3%) non-diabetic amputees were capable of independent outdoor and indoor walking without cane, respectively. With assistance of cane, most of non-diabetic amputees (n=24, 92.3%) were capable of walking in both outdoor and indoor but only seven (38.9%) and nine (50.0%) diabetic amputees were capable, respectively. Thus, short-term walking outcome were poor in transtibial amputee with diabetes compare to those without diabetes, and these results suggest intensive rehabilitation would be needed to them.

Citations

Citations to this article as recorded by  

• Evolution of a Cohort of COVID-19 Infection Suspects Followed-Up from Primary Health Care
  Valle Coronado-Vázquez, Maria del Valle Ramírez-Durán, Juan Gómez-Salgado, María Silvia Dorado-Rabaneda, Elena Benito-Alonso, Marina Holgado-Juan, Cristina Bronchalo-González
  Journal of Personalized Medicine.2021; 11(6): 459.     CrossRef